期刊文献+
共找到146,787篇文章
< 1 2 250 >
每页显示 20 50 100
中国高血压防治指南2010 被引量:1220
1
作者 刘力生 《中国医学前沿杂志(电子版)》 2011年第5期42-93,共52页
序言 高血压是最常见的慢性病,也是心脑血管病最主要的危险因素,其脑卒中、心肌梗死、心力衰竭及慢性肾脏病等主要并发症,不仅致残、致死率高,而且严重消耗医疗和社会资源,给家庭和国家造成沉重负担。
关键词 HYPERTENSION drug therapy Disease management GUIDELINES
下载PDF
黄酮类化合物生理活性及合成研究进展 被引量:336
2
作者 延玺 刘会青 +1 位作者 邹永青 任占华 《有机化学》 SCIE CAS CSCD 北大核心 2008年第9期1534-1544,共11页
黄酮类化合物是一类植物次生代谢产物,广泛存在于多种植物中,不仅数量种类繁多,而且结构类型复杂多样.黄酮类化合物因其独特的化学结构而对哺乳动物和其它类型的细胞具有许多重要的生理、生化作用,是许多中草药的有效成分.据报道,适量... 黄酮类化合物是一类植物次生代谢产物,广泛存在于多种植物中,不仅数量种类繁多,而且结构类型复杂多样.黄酮类化合物因其独特的化学结构而对哺乳动物和其它类型的细胞具有许多重要的生理、生化作用,是许多中草药的有效成分.据报道,适量摄入黄酮类化合物能减少癌症、肿瘤、心血管疾病、脂质过氧化以及骨质疏松等疾病的发病率.因此,其引起了国内外化学家的广泛重视,近年来研究进展很快.随着对其构效关系的深入研究,发现了黄酮类化合物部分药理作用的作用机制,为其在医药、食品领域的应用提供了理论依据,加快了黄酮类化合物的开发利用.迄今为止,人们已经合成了一系列溶解性好,具有多种生物活性的黄酮类衍生物.综述了黄酮类化合物的生理活性及其合成研究进展. 展开更多
关键词 黄酮类化合物 药物 生理活性 合成
下载PDF
HIF-1α pathway: role, regulation and intervention for cancer therapy 被引量:151
3
作者 Georgina N.Masoud Wei Li 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2015年第5期378-389,共12页
Hypoxia-inducible factor-1 (HIF-1) has been recognized as an important cancer drug target. Many recent studies have provided convincing evidences of strong correlation between elevated levels of HIF-1 and tumor metast... Hypoxia-inducible factor-1 (HIF-1) has been recognized as an important cancer drug target. Many recent studies have provided convincing evidences of strong correlation between elevated levels of HIF-1 and tumor metastasis, angiogenesis, poor patient prognosis as well as tumor resistance therapy. It was found that hypoxia (low O<sub>2</sub> levels) is a common character in many types of solid tumors. As an adaptive response to hypoxic stress, hypoxic tumor cells activate several survival pathways to carry out their essential biological processes in different ways compared with normal cells. Recent advances in cancer biology at the cellular and molecular levels highlighted the HIF-1α pathway as a crucial survival pathway for which novel strategies of cancer therapy could be developed. However, targeting the HIF-1α pathway has been a challenging but promising progresses have been made in the past twenty years. This review summarizes the role and regulation of the HIF-1α in cancer, and recent therapeutic approaches targeting this important pathway. 展开更多
关键词 HIF-1Α HIF-1α inhibitors Cancer drug discovery and development
原文传递
异丙酚的剂量与镇静和呼吸抑制作用之间的关系 被引量:143
4
作者 王祥瑞 杭燕南 +1 位作者 孙大金 金正均 《中华麻醉学杂志》 CAS CSCD 北大核心 1997年第10期590-592,共3页
研究不同剂量的异丙酚的量效关系。方法:选择50例甲状腺腺瘤切除病人,随机分为5组,Ⅰ组,0.5mg/kg、Ⅱ组0.75mg/kg、Ⅲ组1.0mg/kg、Ⅳ组1.5mg/kg、V组2.0mg/kg.采用Star呼吸机监测呼吸功能指标,同时观察其神志变化,应用Probit法分析该药... 研究不同剂量的异丙酚的量效关系。方法:选择50例甲状腺腺瘤切除病人,随机分为5组,Ⅰ组,0.5mg/kg、Ⅱ组0.75mg/kg、Ⅲ组1.0mg/kg、Ⅳ组1.5mg/kg、V组2.0mg/kg.采用Star呼吸机监测呼吸功能指标,同时观察其神志变化,应用Probit法分析该药量效关系。结果:Ⅱ、IV、V组随着剂量增加,潮气量降低的幅度和呼吸抑制持续时间明显增加,以给药后1~3分钟潮气量减少最为明显(P<0.01),浅睡状态ED_(50)为0.98mg/kg.深睡状态ED_(50)为1.26mg/kg,呼吸抑制ED_(50)为1.1mg/kg。结论:静注0.8~1mg/kg异丙酚可以产生适用于非全麻病人的镇静、催眠作用,而对呼吸抑制的作用较小。 展开更多
关键词 异丙酚 镇静 呼吸功能试验 剂量
原文传递
Nano-Graphene Oxide for Cellular Imaging and Drug Delivery 被引量:123
5
作者 Xiaoming Sun Zhuang Liu +4 位作者 Kevin Welsher Joshua Tucker Robinson Andrew Goodwin Sasa Zaric Hongjie Dai 《Nano Research》 SCIE EI CSCD 2008年第3期203-212,共10页
Two-dimensional graphene offers interesting electronic,thermal,and mechanical properties that are currently being explored for advanced electronics,membranes,and composites.Here we synthesize and explore the biologica... Two-dimensional graphene offers interesting electronic,thermal,and mechanical properties that are currently being explored for advanced electronics,membranes,and composites.Here we synthesize and explore the biological applications of nano-graphene oxide(NGO),i.e.,single-layer graphene oxide sheets down to a few nanometers in lateral width.We develop functionalization chemistry in order to impart solubility and compatibility of NGO in biological environments.We obtain size separated pegylated NGO sheets that are soluble in buffers and serum without agglomeration.The NGO sheets are found to be photoluminescent in the visible and infrared regions.The intrinsic photoluminescence(PL)of NGO is used for live cell imaging in the near-infrared(NIR)with little background.We found that simple physisorption viaπ-stacking can be used for loading doxorubicin,a widely used cancer drug onto NGO functionalized with antibody for selective killing of cancer cells in vitro.Owing to its small size,intrinsic optical properties,large specifi c surface area,low cost,and useful non-covalent interactions with aromatic drug molecules,NGO is a promising new material for biological and medical applications. 展开更多
关键词 Graphene oxide PEGYLATION size separation cellular imaging drug delivery
原文传递
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes:current perspectives and future challenges 被引量:114
6
作者 Dinh Ha Ningning Yang Venkatareddy Nadithe 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2016年第4期287-296,共10页
Exosomes are small intracellular membrane-based vesicles with different compositions that are involved in several biological and pathological processes. The exploitation of exosomes as drug delivery vehicles offers im... Exosomes are small intracellular membrane-based vesicles with different compositions that are involved in several biological and pathological processes. The exploitation of exosomes as drug delivery vehicles offers important advantages compared to other nanoparticulate drug delivery systems such as liposomes and polymeric nanoparticles; exosomes are non-immunogenic in nature due to similar composition as body's own cells. In this article, the origin and structure of exosomes as well as their biological functions are outlined. We will then focus on specific applications of exosomes as drug delivery systems in pharmaceutical drug development. An overview of the advantages and challenges faced when using exosomes as a pharmaceutical drug delivery vehicles will also be discussed. 展开更多
关键词 EXOSOMES NANOCARRIER EXTRACELLULAR vesicles drug delivery systems
原文传递
2002-2014年中国免费艾滋病抗病毒治疗进展 被引量:102
7
作者 豆智慧 张福杰 +4 位作者 赵燕 晋灿瑞 赵德才 甘秀敏 马烨 《中华流行病学杂志》 CAS CSCD 北大核心 2015年第12期1345-1350,共6页
目的 分析艾滋病“四免一关怀”政策实施12年来中国免费艾滋病治疗进展特征.方法 采用回顾性队列研究和多次横断面调查分析,从全国艾滋病综合防治信息系统治疗库中收集2002-2014年所有免费艾滋病抗病毒治疗者368449例,选取其治疗基线信... 目的 分析艾滋病“四免一关怀”政策实施12年来中国免费艾滋病治疗进展特征.方法 采用回顾性队列研究和多次横断面调查分析,从全国艾滋病综合防治信息系统治疗库中收集2002-2014年所有免费艾滋病抗病毒治疗者368449例,选取其治疗基线信息(开始治疗日期、CD4+T淋巴细胞计数、治疗药物方案)和随访信息[随访日期、CD4+T淋巴细胞(CD4)计数、病毒载量、随访状态],分析治疗进展和效果.结果 共368 449例艾滋病病毒感染者/艾滋病患者(HIV/AIDS)接受治疗.新治例数逐年增长,2010-2014年新治者占70.4%.治疗基线CD4计数<200 cells/μl者和临床诊断AIDS的构成比,从2006年的81.0%降至2014年39.7%.截至2014年底,拉米夫定替换去羟肌苷、依非韦仑替换奈韦拉平、替诺福韦替换司他夫定,这3种药物优化方案的使用率分别为99.5%、75.7%和60.6%.艾滋病治疗与管理由疾病预防控制中心主导平稳转交至医院,治疗县/区占全国县/区的75.4%.每年2次CD4检测比例,2010年以后为75.2%.每年1次病毒载量检测比例,从2010年70.8%增至2014年87.4%.病毒载量检测者病毒学失败率从2010年17.6%降至2014年11.8%.所有接受治疗者1、5、10年生存率分别为92.2%、80.5%和69.6%,其中基线CD4计数<50 cells/μl和>350 cells/μl者1、5、10年生存率分别为81.6%、69.9%、60.9%和97.9%、89.8%、81.0%.结论 我国免费艾滋病抗病毒治疗项目是一个人数规模巨大的动态治疗队列,药物与治疗标准跟进WHO推荐的药物和标准,所有接受治疗者10年生存率为65%.同时,随着治疗人数大幅增长而不断增加的经费、药品、人力需求等,艾滋病抗病毒治疗也面临着严峻的挑战. 展开更多
关键词 艾滋病病毒 高效抗反转录病毒治疗 药物 监测 生存率 病毒学失败率
原文传递
10省市抗精神病药使用现况的调查 被引量:95
8
作者 司天梅 舒良 +11 位作者 于欣 马崔 王高华 白培深 刘协和 纪丽萍 师建国 陈宪生 梅其一 栗克清 张鸿燕 马弘 《中华精神科杂志》 CAS CSCD 北大核心 2004年第3期152-155,共4页
目的 调查中国10省市精神药物治疗精神分裂症的使用现状。方法 按人均国内生产总值将各省分为五个经济发展等级,以一定的抽样比例,选择10个省市的46家精神疾病专科医院或综合医院精神科的4779例住院和门诊精神分裂症患者,于2002年5月20... 目的 调查中国10省市精神药物治疗精神分裂症的使用现状。方法 按人均国内生产总值将各省分为五个经济发展等级,以一定的抽样比例,选择10个省市的46家精神疾病专科医院或综合医院精神科的4779例住院和门诊精神分裂症患者,于2002年5月20-24日用自制调查问卷进行精神分裂症药物治疗的现况调查。结果 (1)在4779例患者中,门诊为1969例(41.20%),住院为2810例(58.80%)。与门诊患者比较,住院患者中的男性患者比例高、年龄大、病程长、公费医疗比例高(均P<0.01)。(2)使用频率在前六位的药物依次是氯氮平、利培酮、舒必利、氯丙嗪、奋乃静和氟哌啶醇。换算为氯丙嗪等效剂量后,治疗剂量为12.5-4125 mg/d,平均(365±253)mg/d。其中住院患者的使用剂量[(409±274)mg/d]高于门诊患者[(300±201)mg/d;F=223,P<0.01]。(3)2617例次(54.99%)使用典型抗精神病药,2940例次(61.78%)使用非典型抗精神病药(包括氯氮平在内)。312例接受长效抗精神病药。3523例(74.03%)接受单一抗精神病药治疗,1236例(25.97%)联合使用2种及其以上抗精神病药。(4)常见的合并治疗药物有抗胆碱能药、β-受体阻断剂、苯二氮(?)类药、抗抑郁药和心境稳定剂。结论 国内精神分裂症药物处方方式逐渐以非典型抗精神病药占主流,经济负担和患者的症状? 展开更多
关键词 抗精神病药 调查 药物治疗 精神分裂症
原文传递
Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China 被引量:94
9
作者 TAO Li-li HU Bi-jie +7 位作者 HE Li-xian WEI Li XIE Hong-mei WANG Bao-qing LI Hua-ying CHEN Xue-hua ZHOU Chun-mei DENG Wei-wu 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第17期2967-2972,共6页
Background Appropriate antimicrobial therapy of community-acquired pneumonia (CAP) is mainly based on the distribution of etiology and antimicrobial resistance of major pathogens. We performed a prospective observat... Background Appropriate antimicrobial therapy of community-acquired pneumonia (CAP) is mainly based on the distribution of etiology and antimicrobial resistance of major pathogens. We performed a prospective observational study of adult with CAP in 36 hospitals in China. Methods Etiological pathogens were isolated in each of the centers, and all of the isolated pathogens were sent to Zhongshan Hospital for antimicrobial susceptibility tests using agar dilution. Results A total of 593 patients were enrolled in this study, and 242 strains of bacteria were isolated from 225 patients. Streptococcus pneumoniae (79/242, 32.6%) was the most frequently isolated pathogen, followed by Haemophilus influenzae (55/242, 22.7%) and Klebsiella pneumoniae (25/242, 10.3%). Totally 527 patients underwent serological tests for atypical pathogens; Mycoplasma pneumoniae and Chlamydia pneumoniae infections were identified in 205 (38.9%) and 60 (11.4%) patients respectively. Legionella pneumophila infections were identified in 4.0% (13/324) of patients. The non-susceptibility rate of isolated Streptococcus pneumoniae to erythromycin and penicillin was 63.2% and 19.1% respectively. Six patients died from the disease, the 30-day mortality rate was 1.1% (6/533). Conclusions The top three bacteria responsible for CAP in Chinese adults were Streptococcus pneumonia, Haemophilus influenza and Klebsiella pneumonia. There was also a high prevalence of atypical pathogens and mixed pathogens. The resistance rates of the major isolated pathogens were relatively low except for the high prevalence of macrolide resistance in Streptococcus pneumoniae. 展开更多
关键词 community-acquired infection PNEUMONIA ETIOLOGY antimicrobial drug resistance EPIDEMIOLOGY
原文传递
全国多中心急性药物性肝损伤住院病例调研分析 被引量:88
10
作者 许建明 《中华消化杂志》 CAS CSCD 北大核心 2007年第7期439-442,共4页
目的回顾性调查我国多中心急性药物性肝损伤住院患者的诊治情况,对急性药物性肝损伤病例进行关联性评价。方法收集全国13个地区16家大型医院2000年至2005年期间因急性药物性肝损伤住院病例及其肝损伤病史和住院诊治经过。采用急性药物... 目的回顾性调查我国多中心急性药物性肝损伤住院患者的诊治情况,对急性药物性肝损伤病例进行关联性评价。方法收集全国13个地区16家大型医院2000年至2005年期间因急性药物性肝损伤住院病例及其肝损伤病史和住院诊治经过。采用急性药物性肝损伤国际共识意见的量化评分系统.评价药物与肝损伤的相关程度并列出可能导致急性药物性肝损伤的主要药物。结果全国16家医院报告的急性药物肝损伤5年间住院诊治数共1541例,住院病例有逐渐增加趋势。在可供进行关联性评价的1204例中,急性药物性肝损伤与药物之间的关联性程度及其比例依次为:极有可能(评分>8分)占14.3%.很可能有关(6~8分)占39.6%,可能有关(3~5分)占40.9%,可能无关(1~2分)占3.8%,无关(≤0分)占1.3%。在药物与肝损伤相关的1142例中,男女比例接近,平均年龄(45.7±16.7)岁,重症药物性肝损伤76例(6.65%),死亡17例,病死率1.5%。导致急性肝损伤的药物种类繁多。其中以中成药或中草药(21.5%)和抗结核药物(21.2%)为多见。结论我国急性药物性肝损伤住院诊断病例数有逐年增加趋势,国际共识意见的量化评分系统有助于重新审定急性肝损伤与药物之间的关联程度,抗结核药物和中成药或中草药可能是我国急性药物性肝损伤的主要病因。 展开更多
关键词 肝脏疾病 药物 诊断
原文传递
Autophagy and multidrug resistance in cancer 被引量:77
11
作者 Ying-Jie Li Yu-He Lei +5 位作者 Nan Yao Chen-Ran Wang Nan Hu Wen-Cai Ye Dong-Mei Zhang Zhe-Sheng Chen 《Chinese Journal of Cancer》 SCIE CAS CSCD 2017年第8期342-351,共10页
Multidrug resistance(MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence.Therefore, combatting MDR is an important issue. Autophagy, a self-degradative system, univ... Multidrug resistance(MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence.Therefore, combatting MDR is an important issue. Autophagy, a self-degradative system, universally arises during the treatment of sensitive and MDR cancer. Autophagy can be a double-edged sword for MDR tumors: it participates in the development of MDR and protects cancer cells from chemotherapeutics but can also kill MDR cancer cells in which apoptosis pathways are inactive. Autophagy induced by anticancer drugs could also activate apoptosis signaling pathways in MDR cells, facilitating MDR reversal. Therefore, research on the regulation of autophagy to combat MDR is expanding and is becoming increasingly important. We summarize advanced studies of autophagy in MDR tumors, including the variable role of autophagy in MDR cancer cells. 展开更多
关键词 AUTOPHAGY drug resistance NEOPLASMS CELL SURVIVAL CELL DEATH
下载PDF
中国老年人潜在不适当用药目录的研制 被引量:78
12
作者 闫妍 王育琴 +4 位作者 沈芊 姜德春 李晓玲 刘琛 李星炜 《药物不良反应杂志》 CSCD 2015年第1期19-26,共8页
目的 初步建立中国老年人潜在不适当用药(PIM)目录,为防范和降低我国老年人群的用药风险提供参考. 方法 以美国、加拿大、日本、法国、挪威、德国、韩国和奥地利的老年人PIM目录为基础,参考我国国家药品不良反应监测中心、全军药品不... 目的 初步建立中国老年人潜在不适当用药(PIM)目录,为防范和降低我国老年人群的用药风险提供参考. 方法 以美国、加拿大、日本、法国、挪威、德国、韩国和奥地利的老年人PIM目录为基础,参考我国国家药品不良反应监测中心、全军药品不良反应监测中心和北京市药品不良反应监测中心老年人严重不良反应所涉及药物情况以及北京市22家医院老年患者药品不良反应数据,建立中国老年人PIM初始目录.采用德尔菲法对初始目录进行专家论证.第1轮咨询聘请专家32名,根据专家意见对初始目录进行调整,形成修订版目录;第2轮咨询聘请专家38名,根据专家意见对修订版目录进行调整,形成最终版目录. 结果 共遴选出13大类72种/类药物纳入中国老年人PIM目录,每种药物附有1~6个风险点.根据专家评价结果,72种/类药物中35种/类为高风险药物,37种/类为低风险药物.依据用药频度,将72种/类药物分为A、B两级,A级为优先警示药物,24种/类;B级为常规警示药物,48种/类. 结论 初步建立了中国老年人PIM目录,可作为干预和评估我国老年人用药的参考目录. 展开更多
关键词 老年人 目录 药物 德尔菲技术 潜在不适当用药 Beers标准
原文传递
Wnt/b-catenin signaling plays an ever-expanding role in stem cell self-renewal,tumorigenesis and cancer chemoresistance 被引量:75
13
作者 Maryam K.Mohammed Connie Shao +16 位作者 Jing Wang Qiang Wei Xin Wang Zachary Collier Shengli Tang Hao Liu Fugui Zhang Jiayi Huang Dan Guo Minpeng Lu Feng Liu Jianxiang Liu Chao Ma Lewis L.Shi Aravind Athiviraham Tong-Chuan He Michael J.Lee 《Genes & Diseases》 SCIE 2016年第1期11-40,共30页
Wnt signaling transduces evolutionarily conserved pathways which play important roles in initiating and regulating a diverse range of cellular activities,including cell proliferation,calcium homeostasis,and cell polar... Wnt signaling transduces evolutionarily conserved pathways which play important roles in initiating and regulating a diverse range of cellular activities,including cell proliferation,calcium homeostasis,and cell polarity.The role of Wnt signaling in controlling cell proliferation and stem cell self-renewal is primarily carried out through the canonical pathway,which is the best-characterized the multiple Wnt signaling branches.The past 10 years has seen a rapid expansion in our understanding of the complexity of this pathway,as many new components of Wnt signaling have been identified and linked to signaling regulation,stem cell functions,and adult tissue homeostasis.Additionally,a substantial body of evidence links Wnt signaling to tumorigenesis of cancer types and implicates it in the development of cancer drug resistance.Thus,a better understanding of the mechanisms by which dysregulation of Wnt signaling precedes the development and progression of human cancer may hasten the development of pathway inhibitors to augment current therapy.This review summarizes and synthesizes our current knowledge of the canonical Wnt pathway in development and disease.We begin with an overview of the components of the canonical Wnt signaling pathway and delve into the role this pathway has been shown to play in stemness,tumorigenesis,and cancer drug resistance.Ultimately,we hope to present an organized collection of evidence implicating Wnt signaling in tumorigenesis and chemoresistance to facilitate the pursuit of Wnt pathway modulators that may improve outcomes of cancers in which Wnt signaling contributes to aggressive disease and/or treatment resistance. 展开更多
关键词 Cancer drug resistance Cancer stem cells Canonical Wnt b-Catenin WNT
原文传递
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods 被引量:73
14
作者 Canrong Wu Yang Liu +10 位作者 Yueying Yang Peng Zhang Wu Zhong Yali Wang Qiqi Wang Yang Xu Mingxue Li Xingzhou Li Mengzhu Zheng Lixia Chen Hua Li 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2020年第5期766-788,共23页
SARS-CoV-2 has caused tens of thousands of infections and more than one thousand deaths.There are currently no registered therapies for treating coronavirus infections.Because of time consuming process of new drug dev... SARS-CoV-2 has caused tens of thousands of infections and more than one thousand deaths.There are currently no registered therapies for treating coronavirus infections.Because of time consuming process of new drug development,drug repositioning may be the only solution to the epidemic of sudden infectious diseases.We systematically analyzed all the proteins encoded by SARS-CoV-2 genes,compared them with proteins from other coronavirnses,predicted their structures,and built 19 structures that could be done by homology modeling.By performing target-based virtual ligand screening,a total of21 targets(including two human targets)were screened against compound libraries including ZINC drug database and our own database of natural products.Structure and screening results of important targets such as 3-chymotrypsin-like protease(3 CLpro),Spike,RNA-dependent RNA polymerase(RdRp),and papain like protease(PLpro)were discussed in detail.In addition,a database of 78 commonly used antiviral drugs including those currently on the market and undergoing clinical trials for SARS-CoV-2 was constructed.Possible targets of these compounds and potential drugs acting on a certain target were predicted.This study will provide new lead compounds and targets for further in vitro and in vivo studies of SARS-CoV-2,new insights for those drugs currently ongoing clinical studies,and also possible new strategies for drug repositioning to treat SARS-CoV-2 infections. 展开更多
关键词 SARS-CoV-2 drug repurposing Molecular docking Remdesivir Homology modeling
原文传递
湖北地区临床细菌耐药性监测 被引量:64
15
作者 申正义 孙自镛 王洪波 《中华医院感染学杂志》 CAS CSCD 2002年第2期91-93,101,共4页
目的 调查湖北地区临床分离菌对抗菌药物的耐药状况。方法 将湖北地区 15所医院纸片扩散法药敏试验的抑菌环直径输入计算机 ;根据 1999年 NCCL S颁布的准则 ,采用“WHONET- 5”软件完成统计分析。结果 临床分离菌中革兰阳性球菌有增... 目的 调查湖北地区临床分离菌对抗菌药物的耐药状况。方法 将湖北地区 15所医院纸片扩散法药敏试验的抑菌环直径输入计算机 ;根据 1999年 NCCL S颁布的准则 ,采用“WHONET- 5”软件完成统计分析。结果 临床分离菌中革兰阳性球菌有增多趋势 ;金黄色葡萄球菌 (金葡菌 )、大肠埃希菌、铜绿假单胞菌和凝固酶阴性葡萄球菌 (CNS)最常见 ;31.0 %金葡菌和 6 7.6 % CNS对苯唑西林耐药 ,对其他药物的耐药率也高 ;亚胺培南、头孢他啶、阿米卡星和环丙沙星对革兰阴性杆菌 (包括肠杆菌科细菌和非发酵菌 ) ,有良好的抗菌活性 ,但与 1996年监测资料比较 ,敏感率均在显著下降。结论 临床细菌耐药性日益严重 ,应在不同地区开展细菌耐药性监测 ; 展开更多
关键词 抗药性 微生物 细菌 药物监测 湖北
下载PDF
Colorectal cancer: From prevention to personalized medicine 被引量:72
16
作者 Gemma Binefa Francisco Rodríguez-Moranta +1 位作者 àlex Teule Manuel Medina-Hayas 《World Journal of Gastroenterology》 SCIE CAS 2014年第22期6786-6808,共23页
Colorectal cancer(CRC)is a very heterogeneous disease that is caused by the interaction of genetic and environmental factors.CRC develops through a gradual accumulation of genetic and epigenetic changes,leading to the... Colorectal cancer(CRC)is a very heterogeneous disease that is caused by the interaction of genetic and environmental factors.CRC develops through a gradual accumulation of genetic and epigenetic changes,leading to the transformation of normal colonic mucosa into invasive cancer.CRC is one of the most prevalent and incident cancers worldwide,as well as one of the most deadly.Approximately 1235108 people are diagnosed annually with CRC,and 609051 die from CRC annually.The World Health Organization estimates an increase of77%in the number of newly diagnosed cases of CRCand an increase of 80%in deaths from CRC by 2030.The incidence of CRC can benefit from different strategies depending on its stage:health promotion through health education campaigns(when the disease is not yet present),the implementation of screening programs(for detection of the disease in its early stages),and the development of nearly personalized treatments according to both patient characteristics(age,sex)and the cancer itself(gene expression).Although there are different strategies for screening and although the number of such strategies is increasing due to the potential of emerging technologies in molecular marker application,not all strategies meet the criteria required for screening tests in population programs;the three most accepted tests are the fecal occult blood test(FOBT),colonoscopy and sigmoidoscopy.FOBT is the most used method for CRC screening worldwide and is also the primary choice in most population-based screening programs in Europe.Due to its non-invasive nature and low cost,it is one of the most accepted techniques by population.CRC is a very heterogeneous disease,and with a few exceptions(APC,p53,KRAS),most of the genes involved in CRC are observed in a small percentage of cases.The design of genetic and epigenetic marker panels that are able to provide maximum coverage in the diagnosis of colorectal neoplasia seems a reasonable strategy.In recent years,the use of DNA,RNA and protein markers in different biological samples 展开更多
关键词 Colorectal cancer PREVENTION Mass screening Biological markers drug therapy
下载PDF
低剂量与标准剂量结合雌激素联合不同孕激素应用对围绝经期综合征患者骨密度的影响 被引量:72
17
作者 左宏玲 邓燕 +5 位作者 王艳芳 高丽虹 薛薇 朱诗扬 马骁 孙爱军 《中华妇产科杂志》 CAS CSCD 北大核心 2018年第4期243-247,共5页
目的观察低剂量结合雌激素(CEE)与标准剂量CEE联合天然黄体酮或地屈孕酮对围绝经期综合征患者骨密度的影响。方法选取2014年2月至2015年12月就诊于北京协和医院的123例围绝经期综合征患者并以随机数字表法随机分为3组,最终共有107例... 目的观察低剂量结合雌激素(CEE)与标准剂量CEE联合天然黄体酮或地屈孕酮对围绝经期综合征患者骨密度的影响。方法选取2014年2月至2015年12月就诊于北京协和医院的123例围绝经期综合征患者并以随机数字表法随机分为3组,最终共有107例完成试验,其中A组(予低剂量CEE+天然黄体酮)35例、B组(予标准剂量CEE+天然黄体酮)37例、C组(予标准剂量CEE+地屈孕酮)35例,以28 d为1个用药周期,共用药12个周期,用药方案均为连续序贯。于治疗前、治疗后测定腰椎2-4及股骨颈的骨密度、骨代谢指标、血清FSH及雌二醇水平。结果治疗前3组患者间各部位的骨密度、骨代谢指标及FSH、雌二醇水平均无差异(P均〉0.05)。治疗后与治疗前比较:(1)A组患者各部位的骨密度均无明显变化(P均〉0.05);B组、C组患者腰椎2-4的骨密度均显著增加,B组治疗前、后分别为(1.14±0.15)、(1.18±0.14)g/cm2,C组治疗前、后分别为(1.17±0.16)、(1.19±0.15)g/cm^2,分别增加3.0%、2.1%(P均〈0.05),C组左侧股骨颈的骨密度显著增加2.9%[治疗前、后分别为(0.91±0.15)、(0.94±0.16)g/cm^2,P=0.029];(2)3组患者的钙、磷、碱性磷酸酶、钙/肌酐比均显著下降(P均〈0.05);(3)3组患者的FSH水平均显著降低,雌二醇水平均显著升高(P均〈0.01)。结论低剂量与标准剂量的绝经激素治疗(MHT)均可升高雌二醇水平,有效预防绝经后的骨丢失,且标准剂量MHT在此基础上还可增加椎骨及股骨颈的骨密度,临床获益更多。 展开更多
关键词 围绝经期 骨质疏松 绝经后 激素替代疗法 骨密度 雌激素替代疗法 量效应关系 药物
原文传递
多糖药物应用与研究进展 被引量:70
18
作者 时潇丽 姚春霞 +2 位作者 林晓 沈岚 冯怡 《中国新药杂志》 CAS CSCD 北大核心 2014年第9期1057-1062,共6页
多糖不仅具有提高免疫功能、抗肿瘤、抗病毒、降血糖、降血脂等药理作用,而且来源广泛、细胞毒性低,是一种理想的药物和功能性食品开发来源。本文主要对国内上市多糖药物的应用以及多糖药物在化学结构、相对分子质量与相对分子质量分布... 多糖不仅具有提高免疫功能、抗肿瘤、抗病毒、降血糖、降血脂等药理作用,而且来源广泛、细胞毒性低,是一种理想的药物和功能性食品开发来源。本文主要对国内上市多糖药物的应用以及多糖药物在化学结构、相对分子质量与相对分子质量分布、给药途径与剂型、药效学与药动学等方面的研究进展作一综述,以期为多糖药物的研究开发提供一定参考。 展开更多
关键词 多糖 药物 应用 进展
原文传递
抗结核药物性肝损害研究进展 被引量:65
19
作者 安慧茹 吴雪琼 《中国抗生素杂志》 CAS CSCD 北大核心 2010年第10期727-733,共7页
含有异烟肼、利福平、吡嗪酰胺的6个月短程化疗是结核病控制的主要策略。但异烟肼、利福平、吡嗪酰胺均有潜在的肝毒性,均可导致药物性肝损害的发生,常常导致患者依从性下降,导致结核病治疗失败。本文就抗结核药物肝损害的发生率、病理... 含有异烟肼、利福平、吡嗪酰胺的6个月短程化疗是结核病控制的主要策略。但异烟肼、利福平、吡嗪酰胺均有潜在的肝毒性,均可导致药物性肝损害的发生,常常导致患者依从性下降,导致结核病治疗失败。本文就抗结核药物肝损害的发生率、病理学特征、临床表现、发病机制、危险因素和防治等方面进行综述。 展开更多
关键词 结核 肝毒性 抗结核药物
下载PDF
EMT-associated microRNAs and their roles in cancer stemness and drug resistance 被引量:62
20
作者 Guangtao Pan Yuhan Liu +2 位作者 Luorui Shang Fangyuan Zhou Shenglan Yang 《Cancer Communications》 SCIE 2021年第3期199-217,共19页
Epithelial-to-mesenchymal transition(EMT)is implicated in a wide array of malignant behaviors of cancers,including proliferation,invasion,and metastasis.Most notably,previou studies have indicated that both cancer ste... Epithelial-to-mesenchymal transition(EMT)is implicated in a wide array of malignant behaviors of cancers,including proliferation,invasion,and metastasis.Most notably,previou studies have indicated that both cancer stem-like properties and drug resistance were associated with EMT.Furthermore,microRNAs(miRNAs)play a pivotal role in the regulation of EMT phenotype,as a result,some miRNAs impact cancer stemness and drug resistance.Therefore,understanding the relationship between EMT-associated miRNAs and cancer stemness/drug resistance is beneficial to both basic research and clinical treatment.In this review,we preliminarily looked into the various roles that the EMT-associated miRNAs play in the stem-like nature of malignant cells.Then,we reviewed the interaction between EMT-associated miRNAs and the drugresistant complex signaling pathways of multiple cancers including lung cancer,gastric cancer,gynecologic cancer,breast cancer,liver cancer,colorectal cancer,pancreatic cancer,esophageal cancer,and nasopharyngeal cancer.We finally discussed the relationship between EMT,cancer stemness,and drug resistance,as well as looked forward to the potential applications of miRNA therapy for malignant tumors. 展开更多
关键词 CANCER epithelial-to-mesenchymal transition microRNA cancer stem cell cancer stemness drug resistance
原文传递
上一页 1 2 250 下一页 到第
使用帮助 返回顶部